Genetically, HLRCC-associated RCC is characterized by a germline mutation in FH. In HLRCC-associated RCCs, oxidative phosphorylation is impaired; therefore, tumor cells demonstrate a metabolic shift to aerobic glycolysis. The gene discussed is FH; the disease is hereditary leiomyomatosis and renal cell cancer.